NCT00323934 2015-01-08Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaMirati Therapeutics Inc.Phase 1 Completed42 enrolled
NCT00324194 2015-01-08A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic SyndromesMirati Therapeutics Inc.Phase 1 Completed25 enrolled